Supernus Pharmaceuticals, Inc. SEC Filings

Filed On	Filing
04 Nov 2026	Form 4: Gemayel Georges, Director Disposed of 27,277 shares (Other Transaction) · Disposed of 2,989 Restricted Stock Unit (Other Transaction) · Disposed of 77,411 Director Stock Option (Right to Buy) (Other Transaction)
04 Nov 2026	Form 4: Horich William Todd, SVP, Commercial Operations Disposed of 115,125 Restricted Stock Unit (Other Transaction) · Disposed of 8,500 Performance Share Unit (Other Transaction) · Disposed of 140,500 Employee Stock Option (Right to Buy) (Other Transaction)
04 Nov 2026	Form 4: Khattar Jack A., Director Disposed of 2,216,451 shares (Other Transaction) · Disposed of 400,000 Restricted Stock Unit (Other Transaction) · Disposed of 393,433 Performance Share Unit (Other Transaction) · 1 more
04 Nov 2026	Form 4: Dec Timothy C, Senior Vice-President & CFO Disposed of 9,129 shares (Other Transaction) · Disposed of 84,875 Restricted Stock Unit (Other Transaction) · Disposed of 7,250 Performance Share Unit (Other Transaction) · 1 more
04 Nov 2026	Form 4: Barlow Carrolee, Director Disposed of 27,045 shares (Other Transaction) · Disposed of 2,989 Restricted Stock Unit (Other Transaction) · Disposed of 72,975 Director Stock Option (Right to Buy) (Other Transaction)
04 Nov 2026	Form 4: Bhatt Padmanabh P., Sr. VP of IP, CSO Disposed of 18,637 shares (Other Transaction) · Disposed of 9,350 Performance Share Unit (Other Transaction) · Disposed of 110,125 Restricted Stock Unit (Other Transaction) · 1 more
04 Nov 2026	Form 4: Rubin Jonathan, SVP, Chief Medical Officer Disposed of 13,979 shares (Other Transaction) · Disposed of 143,500 Employee Stock Option (Right to Buy) (Other Transaction) · Disposed of 80,125 Restricted Stock Unit (Other Transaction) · 1 more
04 Nov 2026	Form 4: Mottola Frank, SVP, Chief Tech. Ops. Officer Disposed of 19,544 shares (Other Transaction) · Disposed of 110,750 Restricted Stock Unit (Other Transaction) · Disposed of 10,600 Performance Share Unit (Other Transaction) · 1 more
04 Nov 2026	Form 4: Newhall Charles W Iii, Director Disposed of 124,119 shares (Other Transaction) · Disposed of 2,989 Restricted Stock Unit (Other Transaction) · Disposed of 85,316 Director Stock Option (Right to Buy) (Other Transaction)
04 Nov 2026	Form 4: Hudson Frederick M., Director Disposed of 60,413 shares (Other Transaction) · Disposed of 2,989 Restricted Stock Unit (Other Transaction) · Disposed of 85,316 Director Stock Option (Right to Buy) (Other Transaction)
04 Nov 2026	Form 4: Sensenig Bethany, Director Disposed of 44,678 Director Stock Option (Right to Buy) (Other Transaction) · Disposed of 2,989 Restricted Stock Unit (Other Transaction)
02 Nov 2026	Form 4: Khattar Jack A., Director Granted 400,000 Restricted Stock Unit
02 Nov 2026	Form 4: Rubin Jonathan, SVP, Chief Medical Officer Granted 70,000 Restricted Stock Unit
02 Nov 2026	Form 4: Dec Timothy C, Senior Vice-President & CFO Granted 70,000 Restricted Stock Unit
02 Nov 2026	Form 4: Mottola Frank, SVP, Chief Tech. Ops. Officer Granted 100,000 Restricted Stock Unit
02 Nov 2026	Form 4: Horich William Todd, SVP, Commercial Operations Granted 100,000 Restricted Stock Unit
02 Nov 2026	Form 4: Bhatt Padmanabh P., Sr. VP of IP, CSO Granted 100,000 Restricted Stock Unit
02 Nov 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
02 Nov 2026	S-8 POS
02 Nov 2026	S-8 POS

Comments